Consultant Connection

The pharmacy benefit member experience is changing—fast. Access the latest issue to see exactly what’s live for your clients’ members today, what’s launching next and how to position these changes in your next plan conversation.

EncircleRx now covers Zepbound®, FoundayoTM and Wegovy® (oral and injectable) for weight loss program clients, with a member cost share of up to $150 per 30-day prescription—extending GLP-1 access without changing plan design.

The Embarc Benefit Protection® drug list is expanding to include four additional FDA- approved gene therapies effective July 1, 2026. See what else is changing, what’s driving the updates and what your clients need to know.

A fundamental shift in how pharmacy benefits are structured and priced is underway—and your clients will have questions. Stay current on how the new PBS pricing model works, what it means for plan sponsors, and how to position it in your conversations.

The research report examines how cancer trends are shifting within working-age populations and what those shifts mean for employers. It highlights how younger employees experience different cancer types, longer care journeys and new financial and workplace pressures. 

Virtual care solved the access problem. MD Live E-Treatment solves what comes next—clinical quality at scale. With a 7% bounce-back rate, 85% of visits resolved without escalation, and NCQA accreditation in all 50 states, it’s the rare combination of a virtual care provider with that distinction. MD Live is a credible answer to both member convenience demands and direct-to-consumer pressure.

Direct-to-consumer models are gaining ground, and your clients are feeling the pressure. Watch this on-demand session to understand where DTC and emerging direct-to-employer (DTE) models are driving member expectations—and walk away with a practical, incentive-based alternative you can bring to your next client conversation.